Clinical Outcomes of MLC601 (NeuroAiD(TM)) in Traumatic Brain Injury: A Pilot Study

Background: MLC601 is a natural product formulation from Chinese medicine that is extensively studied in ischemic stroke. Traumatic brain injury (TBI) shares pathophysiological mechanisms with ischemic stroke, yet there are few studies on the use of MLC601 in treating TBI. This Indonesian pilot stud...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain Sci
Hlavní autoři: Al Fauzi, Asra, Prihastomo, Krisna Tsaniadi, Ranuh, I. G. M. Aswin R., Apriawan, Tedy, Wahyuhadi, Joni, Parenrengi, M. Arifin, Turchan, Agus, Bajamal, Abdul Hafid, Notobroto, Hari Basuki
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7071378/
https://ncbi.nlm.nih.gov/pubmed/31973204
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/brainsci10020060
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky